Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYTALUX for Intraoperative Detection of Malignant Tissue in Cancer Surgery
NCT07039526Phase 2Recruiting
- Start
- Aug 2025
- Primary completion
- Dec 2027
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of pafolacianine in esophageal cancer, gastrointestinal cancer, gynecologic cancer. Started Aug 2025; status: recruiting.
02
Drugs
pafolacianine
03
Conditions
esophageal cancergastrointestinal cancergynecologic cancer
Beyond the preview
Go deeper on NCT07039526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07039526.